drugset / Trial / NCT00657384
Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy
RandomizedParallel-groupDouble-blindPrevention
Summary
Blood loss was reported as a prognostic risk factor of morbidity and overall survival after hepatic resection. The aim of this study prospective randomized was compare the efficacy of the administration of tranexamic acid versus placebo to reduce perioperative bleeding after major hepatectomy (\> 3 hepatic segments).
Timeline
- Start
- 2008-08-20
- Primary completion
- 2013-08-20
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 10 mg/kg | Intravenous |
Indications
No indication recorded.